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Accepted 5 June 2016A case involving a 13-year-old girl with nonfunctioning pituitarymacroadenoma is discussed. The patient visited
the hospital for checkup after experiencing a head injury secondary to syncope. A computed tomography (CT)
scan revealed a pituitary mass with mildly higher density. Magnetic resonance imaging (MRI) with contrast en-
hancement showed that themass contained a hyperintense area and it elevated the optic chiasm. The patient had
blurred vision in her right eye. No endocrinological abnormalitieswere found.When the patientwas admitted for
surgical removal of themass 1month later, her visual acuity had improved. A repeatMRI showed that the size of
the pituitary mass had dramatically reduced. During the following 2 years, themass showed further reduction in
size and did not re-grow. Since symptoms of pituitary apoplexy were not observed, we believe that asymptom-
atic apoplexy occurring at the time of the ﬁrst visit may have caused regression of the tumor.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Pituitary adenoma
Regression
Nonfunctioning
Apoplexy1. Introduction
Spontaneous regression occurs frequently in cases of hormonally ac-
tive pituitary adenoma but is rare in cases of nonfunctioning adenoma.
We report here a case showing spontaneous regression of a nonfunc-
tioning pituitary adenoma with no accompanying symptoms.
2. Case report
A 13-year-old girl who visited the hospital with a head injury sec-
ondary to syncope was referred to the department of neurosurgery be-
cause of an abnormality revealed by computed tomography (CT) scan
andmagnetic resonance imaging (MRI). The patient reported no symp-
toms but showed diminished eyesight in her right eye and decreased
color perception on the upper right side. She had experiencedmenarche
1 year prior to the visit and reported recent irregularity in hermenstrual
cycle. An initial head CT scan detected a pituitary mass with a large
suprasellar component and an area of slightly increased density
(Fig. 1). MRI performed 3 weeks later showed that the mass was
isointense on both T1- and T2-weighted images. T2-weighted images
showed a small hyperintense area thatwasweakly enhanced by admin-
istration of a contrast agent. The pituitary stalkwas deviated to the right
side, and the optic chiasmwas elevated (Fig. 2). The results of a pituitary
hormone proﬁle were normal: thyroid stimulating hormone (TSH):gnetic resonance imaging; PA,
. This is an open access article under2.1 mIU/ml (normal range: 0.34–3.5); free T3 (FT3): 3.4 pg/ml (normal
range: 2.0–4.0); free T4 (FT4): 1.23 ng/ml (normal range: 0.9–1.8); ad-
renocorticotropic hormone (ACTH): 20.36 pg/ml (normal range:
7.2–63.3); cortisol: 5.8 μg/dl (normal range: 2.7–15.5); human growth
hormone (HGH): 0.78 ng/ml (normal range: 0.11–3.9); luteinizing hor-
mone (LH): 5.5 mIU/ml (normal range: 1.4–15.0); follicle-stimulating
hormone (FSH): 4.8 mIU/ml (normal range: 3.0–10.0); prolactin
(PRL): 10.8 ng/ml (normal range 1.2–12); insulin-like growth factor-1
(IGF-1): 271 ng/ml (normal range: 193–643). The patient was diag-
nosedwith nonfunctioning pituitary adenoma and admitted for surgery
1 month later. She reported no episodes of headache, vomiting, nausea,
or deterioration of vision prior to admission. A repeatMRI on admission
revealed regression of the sellar lesion (Fig. 3a,b). Furthermore, her vi-
sual acuity had returned to normal. Repeated endocrinological testing
showed no abnormalities. The patient was discharged without treat-
ment. MRIwas repeated 4months later and showed a further reduction
in the size of the pituitary mass (Fig. 3c). The patient has attended reg-
ular follow-up visits at the outpatient clinic. Repeated MRI scans during
the 2 years after the initial visit have detected no signs of tumor re-growth.
3. Discussion
Spontaneous regression of pituitary adenoma is frequently reported;
however, the mechanism underlying this phenomenon is unclear. Pre-
vious reports have suggested various factors that may facilitate sponta-
neous regression, such as apoplexy, hormonal ﬂuctuations due to
childbirth, anticoagulation therapy, stress test of pituitary hormone,
and bromocriptine treatment. Many of these reports describe cases ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Initial CT showed a suprasellar mass with slightly higher density.
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rare in cases of nonfunctioning pituitary adenoma.
Spontaneous decreases in volume of nonfunctioning pituitary ade-
nomas have been reported in studies of the natural course of
incidentalomas [1,2]. In a review of studies assessing the natural course
of nonfunctioning macroadenomas, Dekker et al. reported spontaneousFig. 2.MRI revealed a pituitary mass extending to the suprasellar area. The mass was isointense
weighted image (b) and was mildly enhanced by administration of a contrast agent (c, d).regression of tumor volume in 34 out of 304 patients (11%) [2]. Seven
cases of spontaneous regression of nonfunctioning adenoma have
been previously reported (Table 1) [3–8]. The average age of these pa-
tients was 48 years. Four of the patients were female. In 4 cases
(57.1%), tumor regression was caused by pituitary apoplexy (PA). In
one case of asymptomatic nonfunctioning adenoma, spontaneous
intratumoral hemorrhage resulted in tumor regression [6].
Pituitary apoplexy is characterized by sudden severe headaches,
nausea, vomiting, diminished visual acuity, visual ﬁeld deﬁcits, ocular
paresis, ophthalmoplegia, and altered consciousness. Headache is the
most common symptom, followed by visual deﬁcits, nausea, vomiting,
and ocular palsy [9]. In the present case, the patient experienced none
of these symptoms.
CT and MRI are effective tools for the detection of pituitary hemor-
rhage. In cases of PA, CT typically shows patchy or conﬂuent areas of
high density within pituitary lesions, which are caused by the hemor-
rhagic component of most PAs [9]. However, MRI is superior to CT in
its capacity to detect PA. It is well known that MRI signals indicating
blood clots change over time, as do signals indicating cerebral hemor-
rhage [9,10]. MRI performed during the acute phase typically shows
areas of hyperintensity on T1-weighted images and areas of combined
hypo- and hyperintensity on T2-weighted images [9]. In the present
case, although a repeat MRI performed 3 weeks after the initial visit
showed no evidence of intratumoral hemorrhage, a patchy area of
slightly increased density detected by the initial CT scan may have
reﬂected a microhemorrhage.
The optimal treatmentmethod for acute PA is controversial. Surgical
intervention is necessary in the majority of PA cases, though conserva-
tivemanagement may be used in certain cases. Correction of electrolyte
imbalances, hemodynamic stabilization, and corticosteroid repletion
are among the most important initial interventions. Surgical interven-
tion is required in cases of acute deterioration of visual acuity [11,12].on both T1- (a) and T2-weighted (b) images. A hyperintense area was observed on a T2-
Fig. 3. Repeat MRI on admission showed partial regression of intrasellar and suprasellar lesions (a, b). The mass was further reduced in size 2 years after the initial examination (c).
Table 1
Summary of reported cases of nonfunctioning pituitary macroadenomas with complete
spontaneous regression.
Author
[ref.]
Age and
sex
Impaired
hormone
Episode of
apoplexy
Intratumoral
hemorrhage
Treat. Considered cause
of reduction
Zielinski [3] 55F Cortisol + + HR Apoplexy
Liu [4] 66M Panhypo + + HR Apoplexy
Behar [5] 46F Panhypo − Unknown None Unknown
Yoshino [6] 32M None − + None Hemorrhage
35M None Unknown − None Unknown
Kachhara [7] 42M None + Unknown None Apoplexy
Norman [8] 57F Panhypo + + HR Apoplexy
Abbreviations used: ref. - reference number; panhypo. – panhypopituitarism; Treat. -
treatment; HR - hormone replacement.
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ours who show mild visual defects and no concomitant endocrinologi-
cal symptoms [3]. In this case, the patient showed no symptoms at the
time of her clinic visits. Syncope may have been caused by mild apo-
plexy, which may have been reﬂected in the initial CT images. In such
a case, a period of further observation would be necessary because of
the possibility of tumor regression or change of disposition after
follow-up.
The age of the patient described here is less than the average age of
48 years among patients with reported spontaneous regression of non-
functional pituitary adenomas (range: 32–66 years, Table 1). Chentli
et al. reported a case of a 9-year-old boy who was diagnosed with a
somatolactotroph pituitary adenoma that showed spontaneous regres-
sion due to apoplexy [13]. Overall, however, cases of pediatric patients
with regression of nonfunctional pituitary adenomas are rare.
On the other hand, since no pathology has been obtained, we cannot
exclude that this young female patientwho presented around the onset
of puberty may have had physiologic enlargement of her pituitary
gland, followed by spontaneous regression. We believe, however, that
the imaging features with signiﬁcant suprasellar irregular extension
and non-homogeneous enhancement, and stalk deviation speak in
favor of adenoma, however, MRI and CT imaging have not yet shown
sufﬁcient accuracy in the differential [15].
The patient described here was monitored for 2 years following her
initial visit with no signs of tumor recurrence. Kamiya et al. reported a
case involving a 22-year-old woman who experienced a recurrence of
Cushing's disease after long-term remission due to PA [14]. In the pres-
ent case, although MRI showed complete disappearance of the original
adenoma, it is unlikely that all of the tumor cells were destroyed, andtherefore there may be a risk of recurrence. Thus, patients with sponta-
neous regression of pituitary adenomas such as the patient discussed
here require careful follow-up study.4. Conclusion
In this case report, we describe a patient with spontaneous regres-
sion of nonfunctioning pituitary adenoma. Though this is a relatively
rare pathology, it is important for surgeons tomonitor the volume of tu-
mors prior to surgery in order to potentially avoid an unnecessary
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